ID: ALA105059

Max Phase: Preclinical

Molecular Formula: C7H18NO+

Molecular Weight: 132.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC[N+](C)(C)CCO

Standard InChI:  InChI=1S/C7H18NO/c1-4-5-8(2,3)6-7-9/h9H,4-7H2,1-3H3/q+1

Standard InChI Key:  VFDZFKXFURHHDU-UHFFFAOYSA-N

Associated Targets(non-human)

Creatine transporter 104 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 132.23Molecular Weight (Monoisotopic): 132.1383AlogP: 0.47#Rotatable Bonds: 4
Polar Surface Area: 20.23Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.97CX Basic pKa: CX LogP: -3.78CX LogD: -3.78
Aromatic Rings: 0Heavy Atoms: 9QED Weighted: 0.55Np Likeness Score: 0.72

References

1. Geldenhuys WJ, Lockman PR, McAfee JH, Fitzpatrick KT, Van der Schyf CJ, Allen DD..  (2004)  Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter.,  14  (12): [PMID:15149650] [10.1016/j.bmcl.2004.04.020]

Source